Prices delayed by at least 15 minutes | Print


Heartbeam (BEAT)

Common Shares
Sell: $1.61|Buy: $2.04|Change: 0.03 (1.73%)

Open 

$1.99


Previous close 

$1.966


Trade high 

$2.05


Volume 

23,121


Year high 

$3.74


Year low 

$1.06


Dividend yield 

-


Market capitalisation 

$52.66 mn


P/E ratio 

149.25


ISIN 

US42238H1086


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Performance 26/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Heartbeam+ 1.73
More...

Company profile

HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.